Shinva Medical Instrument Co (600587) Fair Value & Analysis
Healthcare · CN · Market cap 7.8B CNY
Fair value as of: Aug 9, 2026
From 26 valuation models · updated yesterday
Share price +5.9% over the past month.
A solid business, screening 49% undervalued on our models.
What matters now
- The price is below even our cautious bear case (¥14.32). The market is more pessimistic than our downside scenario.
- Solid quality (51/100) at a price below fair value, the discount is the argument here, not the business quality.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 9, 2026.
How to read this chart
60‑month range ¥11.50 – ¥36.21 · fair‑value band ¥14.32 – ¥23.86 · the ¥12.79 price screens below the ¥19.09 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 9, 2026.
Analysis
Shinva Medical Instrument Co (600587) currently trades at ¥12.79, while our model-based Fair Value estimate is ¥19.09, implying the stock looks roughly 49.3% undervalued today. The Quality Score stands at 51/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, Shinva Medical Instrument Co generated revenue of 9.7B CNY at a net margin of 5.1%. Revenue declined 2.3% year over year. It earns a return on equity of 6.0%. The balance sheet holds a net cash position of 1.9B CNY. Fundamentals as of Aug 9, 2026
Our scenario range runs from ¥14.32 (bear case) to ¥23.86 (bull case); at ¥12.79, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 31% below its 52-week high and 3% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -22% fair-value upside, at 49%, 600587 screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 26 models by family
Widest divergence: DCF Models (¥21.93) versus Asset-Based (¥8.43). Highest evidence: Growth DCF (80).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 9, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 51 · Market factors (momentum, volatility) 37
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Shinva Medical Instrument Co.,Ltd. provides medical devices, pharmaceutical equipment, medical services, and medical trade in the People's Republic of China.
Full company description
Shinva Medical Instrument Co.,Ltd. provides medical devices, pharmaceutical equipment, medical services, and medical trade in the People's Republic of China. The company offers medical devices, including infection control instruments such as washing disinfection, sterilization, and consumables; radiotherapy equipment; and surgical instruments and biomedical consumables comprising standard, neuro, cardiovascular, ENT, imaging system laparoscopic, orthopedic, urological, intestinal and rectum, abdominal, plastic surgical, gynecologic and obstetric, micro, arthroscopic, ophthalmic, oral, stainless steel ware, sterilization container, and thoracoscopic small incision instruments. It also provides operating room integrated solutions, such as operating tables, medical ceiling pendants, surgical lights, and medical air disinfectors; dental units and sterilizers; and laboratory equipment, including washing equipment, air disinfectors, disinfection transfer chambers, bedding collection tables, drinking sterilization equipment, biosafety barrier solutions, vertical sterilizers, and independent ventilation cages (IVC), as well as hemodialyzers, medical environmental protection, and in vitro diagnostics. In addition, the company offers pharmaceutical equipment comprising large volume injection solutions; small volume injection solutions, such as plastic bottle BFS machines, filling lines, and freeze dryers; and aseptic guarantee systems that include washing machines and isolators. Shinva Medical Instrument Co.,Ltd. was founded in 1943 and is headquartered in Zibo, China.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Shinva Medical Instrument Co reported revenue of ¥9.7B in FY2025 versus ¥9.5B in FY2021, a compound +0.7%/yr. Reported net income was ¥526M in FY2025, compounding −1.4%/yr from FY2021.
Watch 600587: get an alert when its fair value changes →
Peer Group
Medical Devices · 351 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Devices median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Devices stocks, each showing price versus our Fair Value estimate (as of Aug 9, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Abbott Laboratories, ABT | $100.68 | $74.79 | -26% |
| Stryker Corporation SYK | $316.44 | $186.28 | -41% |
| Medtronic plc MDT | $83.56 | $65.57 | -22% |
| Boston Scientific Corporation BSX | $43.04 | $38.44 | -11% |
| Edwards Lifesciences Corporation EW | $85.73 | $41.02 | -52% |
| Siemens Healthineers AG SHL | €34.59 | €33.87 | -2% |
| Shenzhen Mindray Bio-Medical Electronics Co 300760 | ¥149.43 | ¥147.63 | -1% |
| Shanghai United Imaging Healthcare Co 688271 | ¥109.00 | ¥43.60 | -60% |
| Demant A/S DEMANT | kr 276.60 | kr 161.17 | -42% |
| Getinge AB GETIB | kr 206.80 | kr 192.14 | -7% |
Compare Shinva Medical Instrument Co with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Shinva Medical Instrument Co (600587) overvalued or undervalued?
What is the fair value of 600587?
What is the quality score of 600587?
What is the revenue of Shinva Medical Instrument Co (600587)?
What is the net profit margin of 600587?
Does Shinva Medical Instrument Co pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Shinva Medical Instrument Co and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.